Skip to search.
 FTSE 100 Up 0.42%
Streaming
Ticker Tape: On

More On CTIC.MI

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Cell Therapeutics, Inc. (CTIC.MI)

-Milan Ticker: 934883/ISIN: US1509348835
2.32 Down 0.02(1.02%) 16:38
Add to Portfolio
Prev Close:2.35
Open:2.32
Bid:2.32
Ask:2.32
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:2.28 - 2.38
52wk Range:0.76 - 2.38
Volume:2,034,056
Avg Vol (3m):1,826,740
Market Cap:326.98m
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.53
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cell Therapeutics, Inc., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback